CMS Issues Proposed Rule Regarding Medicaid Drug Rebate Program
In late-May, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule entitled Misclassification of Drugs,…
Author
CMMI Update on Health Equity
In October of 2021, the CMS Center for Medicare and Medicaid Innovation (CMMI) unveiled its 2030 vision to achieve “equitable…
CMS Set to Scrutinize Medicare Advantage Marketing
In a May 10 letter to Medicare Advantage organizations and prescription drug plans, CMS said it will more closely scrutinize more…
Novartis Executives Cleared of Bribery Allegations
Four former Novartis executives were recently cleared of bribery charges after a seven-year investigation into allegations that…
San Francisco and Walgreens Reach $230 Million Settlement Over Opioid…
San Francisco recently reached a nearly $230 million settlement with Walgreens Boots Alliance Inc over its alleged role in the…
Gilead Succeeds in HIV Drug Patent Case Against the Government
After a weeklong trial, a federal jury ruled against the federal government, finding that Gilead Sciences Inc. did not infringe…
FTC Deepens Probe into Pharmacy Benefit Managers
Recently, the United States Federal Trade Commission (FTC) announced that it would expand its probe into pharmacy benefit managers…
Policy and Medicine Compliance Update July 2023 Issue Features: HHS OIG…
Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
Open Payments Program: CMS Quietly Publishes Program Year 2022 Data
With little fanfare on June 30th, the Centers for Medicare & Medicaid Services (CMS) published Program Year (PY) 2022 Open…
HHS OIG Unveils New FAQ Program Expansion
The United States Department of Health and Human Services (HHS) Office of Inspector General (OIG) recently announced a quicker way…